Boris Sommer

Learn More
BACKGROUND Controversy remains about the longevity of correction in autologous fat grafts and its relation to adipocyte survival. Reported long-term fat graft survival rates differ widely, depending on harvesting method, means of reinjection, injection site, and evaluation methods. OBJECTIVE To demonstrate histologic findings of aspirated adipose tissue(More)
BACKGROUND Hyaluronic acid (HA) fillers such as Restylane(®) are frequently used for the correction of facial soft tissue defects. OBJECTIVE To compare the efficacy and safety of a novel HA filler, Emervel(®) Classic, with those of Restylane in the treatment of moderate nasolabial folds. METHODS This was a split-face, randomized and evaluator-blinded(More)
Due to the developments and changes of tumescent solution, infiltration technique, and cannulas, we perform tumescent liposuction today using up to 6-8 l tumescent solution. Total aspirate measures up to 9 l, pure fat aspired up to 5 l. Tumescent liposuction of extended areas can still be done as an outpatient procedure. The condition of patients intra- and(More)
BACKGROUND Tumescent local anesthesia (TLA) with lidocaine or prilocaine solutions is widely used in dermatology. OBJECTIVE Comparison of efficacy and safety of lidocaine and prilocaine in liposuctions with TLA. METHODS TLA was performed using defined dilutions of lidocaine or prilocaine. Half-side comparisons were applied on 26 patients undergoing(More)
Die Tumeszenzlokalanästhesie (TLA) wurde vor 10 Jahren von dem amerikanischen Dermatologen und Pharmakologen J. Klein zur Erleichterung der kosmetischen Fettabsaugung eingeführt. Nachdem sich diese Form der großen Lokalanästhesie außerordentlich gut bewährt hatte, wurden ihre speziellen Vorteile nach und nach auch für andere Indikationen genutzt, ein(More)
BACKGROUND Soft tissue augmentation using autologous fat is a standard method in facial rejuvenation and in refinement of body contouring. Different procedures by different authors have been described, each with its specific advantages and disadvantages. OBJECTIVE The purpose of this article is to describe a method of harvesting, processing, and(More)
Botulinum toxin type A treatment is the foundation of minimally invasive aesthetic facial procedures. Clinicians and their patients recognize the important role, both negative and positive, that facial expression, particularly the glabellar frown lines, plays in self-perception, emotional well-being, and perception by others. This article provides(More)
OBJECTIVE To gain first evidence on the patient satisfaction after treatment with botulinum toxin type A (BTX-A) and to check for differences in satisfaction with respect to clinical, psychologic, and sociodemographic parameters. METHODS In this pilot study, 30 patients who had been treated with BTX-A within the last 3 months answered a standardized(More)
The botulinum neurotoxin (BoNT) product Azzalure (manufactured by Ipsen Biopharm Limited, Wrexham, UK; distributed by Galderma), measured in Speywood units (s.U) has been available since 2009 for temporary improvement in the appearance of moderate to severe glabellar lines. Although we know much about the use of Azzalure for aesthetic indications, some(More)